Microbot Medical, Inc.
(NASDAQ : MBOT)

( )
MBOT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.87%285.761.5%$877.84m
GILDGilead Sciences, Inc. -0.19%87.791.0%$684.30m
MRNAModerna, Inc. 3.15%179.000.0%$651.73m
REGNRegeneron Pharmaceuticals, Inc. 2.25%764.272.6%$499.64m
VRTXVertex Pharmaceuticals, Inc. 1.85%317.581.9%$473.10m
BIIBBiogen, Inc. 0.23%292.151.8%$407.81m
ILMNIllumina, Inc. 1.23%208.523.2%$225.94m
BMRNBioMarin Pharmaceutical, Inc. 1.44%103.694.2%$162.19m
BNTXBioNTech SE 0.63%162.630.0%$150.70m
AXSMAxsome Therapeutics, Inc. 3.85%78.161.6%$146.95m
SNSSSunesis Pharmaceuticals, Inc. -3.98%1.930.7%$134.91m
RXDXPrometheus Biosciences, Inc 165.67%95.801.4%$103.84m
MRTXMirati Therapeutics, Inc. -30.66%49.591.6%$102.08m
HALOHalozyme Therapeutics, Inc. 2.41%57.7418.4%$82.03m
NVAXNovavax, Inc. 2.62%17.2275.3%$81.88m

Company Profile

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.